News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 334
- Sources here
- 17
- Companies here
- 11
Search results
Stored financial headlines
Active search
334 matching headlines
Ticker or company: UVMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
(NVCT) Movement Within Algorithmic Entry Frameworks
The article analyzes Nuvectis Pharma Inc. (NVCT) using algorithmic entry frameworks, highlighting a weak near-term sentiment that could precede shifts in mid and long-term outlook. It presents exceptional risk-reward short setup opportunities and outlines three distinct institutional trading strategies based on AI models, including …
NVCT
main company
Sharemaestro market context
Trend signal active
52 weeks +176.0% · Next-week setup negative 41.0%
NCDL Q2 2026 Earnings: Credit Losses Weigh on NAV
Nuveen Churchill Direct Lending Corp. (NCDL) reported a decline in Q2 2026 investment income and a significant drop in net assets from operations per share due to lower base rates and substantial realized and unrealized investment losses. While net investment income covered the quarterly …
NCDL
main company
Sharemaestro market context
Price below Trend Line
52 weeks -14.8%
Nuvation Bio (NYSE: NUVB) posts $31.7M Q2 revenue and $62.8M loss
Nuvation Bio (NYSE: NUVB) announced Q2 2026 revenue of $31.7 million, driven by strong sales of its ROS1 inhibitor IBTROZI and collaboration agreements, representing a significant increase from the previous year. Despite the revenue growth, the company reported a net loss of $62.8 million …
NUVB
main company
Sharemaestro market context
Trend signal active
52 weeks +114.5% · Next-week setup positive 55.4%
NCDL|Nuveen Churchill Direct Lending Corp|Price:12.520|Chg%:+0.020
This article provides a detailed overview of Nuveen Churchill Direct Lending Corp (NCDL) stock, including its live price, key financial figures, analyst ratings, and company insights. NCDL is described as a specialty finance company focused on senior secured loans to private equity-owned U.S. middle …
NCDL
main company
Sharemaestro market context
Price below Trend Line
52 weeks -14.8%
Lucid Capital Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $34
Lucid Capital has reiterated its Buy rating on Nuvectis Pharma (NVCT.US) and increased its price target to $34. This update indicates a positive outlook from the investment firm regarding the pharmaceutical company's future performance.
NVCT
main company
Sharemaestro market context
Trend signal active
52 weeks +176.0% · Next-week setup negative 41.0%
(NCDL) as a Liquidity Pulse for Institutional Tactics
This article analyzes Nuveen Churchill Direct Lending Corp. (NASDAQ: NCDL) using AI models to generate trading strategies and sentiment analysis. It identifies a neutral near-term sentiment and potential mid-term weakness, with a specific focus on resistance testing. The report provides distinct trading strategies for …
NCDL
main company
Sharemaestro market context
Price below Trend Line
52 weeks -14.8%
Nuvectis Pharma (NASDAQ: NVCT) boosts cash with $115M stock sale and new drug licenses
Nuvectis Pharma (NASDAQ: NVCT) recently raised $115 million through a public stock offering, generating approximately $106.3 million in net proceeds. This capital, combined with existing cash, is expected to fund operations for at least 12 months. Additionally, the company secured global rights (excluding China …
NVCT
main company
Sharemaestro market context
Trend signal active
52 weeks +176.0% · Next-week setup negative 41.0%
Nuvectis Pharma (NASDAQ:NVCT) Shares Gap Down After Earnings Miss
Nuvectis Pharma (NASDAQ:NVCT) shares gapped down following an earnings miss, with the company reporting a quarterly EPS of negative $0.30 against an estimated negative $0.25. Despite the miss, analyst sentiment is mixed, with some issuing "buy" ratings and higher price targets, while the consensus …
NVCT
main company
Sharemaestro market context
Trend signal active
52 weeks +176.0% · Next-week setup negative 41.0%
Nuvectis Pharma, Inc. 2Q 2026: Net loss $(7.02)M, EPS $(0.30) — 10-Q Summary
Nuvectis Pharma, Inc. reported a net loss of $(7.02)M and an EPS of $(0.30) for Q2 2026, with no revenue generated since inception. The company is advancing its clinical pipeline, including licensing global rights for NXP100 and NXP200, and increasing R&D spending. A recent …
NVCT
main company
Sharemaestro market context
Trend signal active
52 weeks +176.0% · Next-week setup negative 41.0%
Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights
Nuvectis Pharma, a clinical-stage biopharmaceutical company, reported its Q2 2026 financial results and significant business achievements, including the in-licensing of two new drug candidates, ciprocopan (NXP100) and NXP200. The company announced that ciprocopan received marketing approval in China for PNH treatment and successfully raised …
NVCT
main company
Sharemaestro market context
Trend signal active
52 weeks +176.0% · Next-week setup negative 41.0%
Nuveen Multi-Asset Income Fund says sub-advisor merger to Nuveen Asset Management causes no fee or strategy change
The Nuveen Multi-Asset Income Fund (NMAI) announced that the sub-advisory functions previously handled by Teachers Advisors have been transferred to Nuveen Asset Management. This merger, effective August 1, 2026, will not result in any changes to the fund's fees, investment policies, portfolio management team, …
NMAI
main company
Sharemaestro market context
Trend signal active
52 weeks +27.3% · Next-week setup positive 59.3%
NUVEEN MULTI-ASSET INCOME FUND To Go Ex-Dividend On August 14th, 2026 With 0.116 USD Dividend Per Share
NUVEEN MULTI-ASSET INCOME FUND is set to go ex-dividend on August 14th, 2026. Shareholders will receive a dividend of 0.116 USD per share. This information is crucial for investors tracking dividend payouts.
NMAI
main company
Sharemaestro market context
Trend signal active
52 weeks +27.3% · Next-week setup positive 59.3%
Nuveen Multi-Asset Income Fund shifts TAL-managed assets to Nuveen Asset Management after merger
The Nuveen Multi-Asset Income Fund transferred sub-advised assets to Nuveen Asset Management from August 1, 2026. This change followed the merger of Teachers Advisors into Nuveen Asset Management, which concluded on July 31, 2026. Nuveen Asset Management will continue to provide the same services …
NMAI
main company
Sharemaestro market context
Trend signal active
52 weeks +27.3% · Next-week setup positive 59.3%
Nuveen Multi-Asset Income Fund (NYSE: NMAI) moves TAL mandate to NAM
Nuveen Multi-Asset Income Fund (NMAI) has announced that Teachers Advisors, LLC (TAL) has been merged into Nuveen Asset Management, LLC (NAM). As a result, NAM will now manage all Fund assets previously handled by TAL, effective August 1, 2026. The fund states there are …
NMAI
main company
Sharemaestro market context
Trend signal active
52 weeks +27.3% · Next-week setup positive 59.3%
Nuveen Dynamic Municipal Opportunities Fund Revenue Breakdown – NYSE:NDMO
The article provides a revenue breakdown for the Nuveen Dynamic Municipal Opportunities Fund (NYSE: NDMO), highlighting that the United States was the primary contributor to its revenue in recent years. In the last year, the US accounted for $42.49 million USD, following $52.96 million …
NDMO
main company
Sharemaestro market context
Price below Trend Line
52 weeks +9.8% · Next-week setup positive 55.9%
(NPCT) Movement as an Input in Quant Signal Sets
The article analyzes Nuveen Core Plus Impact Fund (NASDAQ: NPCT) focusing on its movement as an input in quantitative signal sets. It identifies a neutral sentiment across all horizons with a mid-channel oscillation pattern and outlines specific trading strategies (long, momentum breakout, and short) …
NPCT
main company
Sharemaestro market context
Price below Trend Line
52 weeks -1.8% · Next-week setup positive 59.7%
Behavioral Patterns of NMAI and Institutional Flows
This article analyzes the behavioral patterns and institutional flows of Nuveen Multi-asset Income Fund Of Beneficial Interest (NASDAQ: NMAI). It highlights a mid-channel oscillation pattern, a 14.0:1 risk-reward setup targeting a 4.0% gain, and a prevailing neutral sentiment. The AI models have generated three …
NMAI
main company
Sharemaestro market context
Trend signal active
52 weeks +27.3% · Next-week setup positive 59.3%
How Nuveen Dynamic Municipal Opportunities Fund Of Beneficial Interest (NDMO) Affects Rotational Strategy Timing
This article analyzes how Nuveen Dynamic Municipal Opportunities Fund Of Beneficial Interest (NDMO) affects rotational strategy timing, identifying a neutral sentiment across all time horizons. It provides AI-generated signals and institutional trading strategies, including long, breakout, and short positions, along with support and resistance …
NDMO
main company
Sharemaestro market context
Price below Trend Line
52 weeks +9.8% · Next-week setup positive 55.9%
NCDL|Nuveen Churchill Direct Lending Corp|Price:12.120|Chg%:-0.090
This article provides a comprehensive stock analysis of Nuveen Churchill Direct Lending Corp (NCDL) by TradingKey. It highlights the company's healthy fundamentals, high growth potential, and fair valuation, alongside a high institutional ownership. The analysis also covers its investment strategy in senior secured loans …
NCDL
main company
Sharemaestro market context
Price below Trend Line
52 weeks -14.8%
Nuvectis Pharma Inc expected to post a loss of 26 cents a share - Earnings Preview
Nuvectis Pharma Inc (NVCT) is projected to report a loss of 26 cents per share, according to this earnings preview. The article, sourced from Reuters, provides an outlook on the company's financial performance.
NVCT
main company
Sharemaestro market context
Trend signal active
52 weeks +176.0% · Next-week setup negative 41.0%